文献速递神经MR

对比剂诱导的齿状核T1高信号:钆双胺与钆塞酸二钠的比较

Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
PubMed 文献 · Invest Radiol · 2017-01-01

回顾性研究纳入132例患者,比较未增强T1WI上齿状核与脑桥信号强度比值;钆双胺≥5次组比值显著高于无对比剂组,而钆塞酸二钠≥5次组及1次组与无对比剂组无显著差异。

要点

  • 多次钆双胺暴露与齿状核T1高信号相关,钆塞酸二钠未显示此关联。
  • 齿状核/脑桥信号比测量观察者间一致性优(ICC 0.835)。
  • 钆塞酸二钠给药剂量仅为钆双胺的四分之一钆量,可能影响结果。

核心结论

  • 未增强T1WI上齿状核高信号与既往钆双胺给药相关,而与钆塞酸二钠无关;两种对比剂给药次数相同,但钆塞酸二钠的钆剂量仅为钆双胺的四分之一,此差异可能影响研究结果。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并豁免知情同意,纳入2000年12月至2016年4月间132例患者(男86例、女46例;平均年龄68.8±11.6岁),分为钆塞酸二钠≥5次组、钆塞酸二钠1次组、无钆对比剂且无慢性肝病组、钆双胺≥5次组。

关键影像表现/征象

  • 钆双胺≥5次组齿状核/脑桥信号比显著高于无对比剂且无慢性肝病组(P<0.0001)。
  • 钆塞酸二钠≥5次组齿状核/脑桥信号比与无对比剂且无慢性肝病组无显著差异(P=0.3912)。
  • 钆塞酸二钠1次组齿状核/脑桥信号比与无对比剂且无慢性肝病组无显著差异(P=1.0000)。

诊断标准与关键数值

  • 齿状核/脑桥信号强度比由2名放射科医师定量测量,观察者间组内相关系数0.835(95%CI 0.767-0.883)。
  • 组间比较采用Dunn检验,以无钆对比剂且无慢性肝病组为对照。

临床应用与阅片要点

  • 阅片时关注未增强T1WI上齿状核信号,多次钆双胺暴露者可见信号增高。
  • 钆塞酸二钠暴露者未观察到齿状核信号显著增高。

局限性

  • 尽管两组钆对比剂给药次数相同,钆塞酸二钠的钆剂量仅为钆双胺的四分之一,此差异可能影响研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate whether an association exists between T1-signal increase in the dentate nucleus (DN) on unenhanced magnetic resonance imaging and previous administration of gadoxetic acid and gadodiamide.

MATERIALS AND METHODS: This retrospective study was approved by the institutional review board; the requirement for informed patient consent was waived. A total of 132 patients (male-female ratio, 86:46; mean age, 68.8 ± 11.6 years) who underwent imaging between December 2000 and April 2016 were divided into 4 groups: patients with 5 or more administrations of gadoxetic acid ("gadoxetic acid ≥5 administrations" group), only 1 administration of gadoxetic acid ("gadoxetic acid 1 administration" group), no gadolinium-based contrast agent (GBCA) administration or chronic liver disease (CLD; "no GBCA administration and no CLD" group), and 5 or more administrations of gadodiamide ("gadodiamide ≥5 administrations" group). Unenhanced T1-weighted images were quantitatively analyzed by 2 radiologists. Intergroup comparison of DN-to-pons signal intensity ratios was performed by the Dunn test, with the no GBCA administration and no CLD group as control. Interobserver agreement was assessed by intraclass correlation coefficients.

RESULTS: The DN-to-pons ratio of the "gadodiamide ≥5 administrations" group was significantly higher (P < 0.0001) and those of the "gadoxetic acid ≥5 administrations" and "gadoxetic acid 1 administration" groups did not differ significantly (P = 0.3912 and 1.0000, respectively) compared with the DN-to-pons ratio of the "no GBCA administration and no CLD" group. The interobserver intraclass correlation coefficient for measurement of DN-to-pons ratio was excellent (0.835; 95% confidence interval, 0.767-0.883).

CONCLUSIONS: Hyperintensity in the DN on unenhanced T1-weighted images is associated with previous administration of gadodiamide but not gadoxetic acid. Although the number of administrations for the 2 GBCA groups was identical, the administered dose of gadoxetic acid was only a quarter the amount of gadolinium as those with gadodiamide. This difference might influence the results of this study.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Ichikawa S, Motosugi U, Omiya Y, et al. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid. Invest Radiol. 2017. PMID: 28195932. doi:10.1097/RLI.0000000000000360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。